Abstract
The application of nanotechnology to stem cell research and development has made great strides during the last years. Nanotechnology offers a new opportunity for the research and development of stem cells. The mammary gland is a dynamic organ that undergoes extensive morphogenesis during the different stages of embryonic development, puberty, pregnancy, lactation and involution. There are multipotent stem cells that reside in mammary tissue (MaSCs) with the ability to self-renew and even differentiate into all types of mammary cells. To identify, characterize, and differentiate MaSCs, a variety of methods have been used to understand the signal transduction pathways that promote their self-renewal and their cellular fate. In the last decade, stem cell therapy has become a promising and modern topic of scientific research, which has raised great expectations. However, by itself, it presents some problems that have been overcome with the use of nanoparticles (NPs). A triple function has been accomplished: transport of drugs or biomolecules that help in the differentiation and proliferation of stem cells, cell targeting and contrast agents for real-time monitoring and obtaining bioimages for diagnostic and detection systems. The main objective of applying stem cells in conjunction with NPs is to control cellular activity, mainly the regenerative capacity of mammary tissue against diseases such as mastitis or to optimize milk production. In this review, we provide a current overview of the application of nanomaterials on stem cells, specifically bovine stem cells in both the mammary gland and milk, as they are a potential source of cell progenitors with potential characteristics and could be used in potential therapies based on these cells.
Keywords: Stem cells, nanotechnology, bovine mammary stem cells, milk stem cells, nanoparticles, nanomaterials.
Graphical Abstract
Nanoscience & Nanotechnology-Asia
Title:Stem Cells and Nanoparticles in Therapy
Volume: 11 Issue: 5
Author(s): Viteri Marco, Toscano Fernanda, Gavilanes Alex, Torres Arias Marbel and Seqqat Rachid*
Affiliation:
- Departamento de Ciencias de la Vida, Laboratorio de Inmunología y Virología, Universidad de las Fuerzas Armadas ESPE, Av. Gral. Rumiñahui s/n, P.O. Box 171-5-231B, Sangolquí,Ecuador
Keywords: Stem cells, nanotechnology, bovine mammary stem cells, milk stem cells, nanoparticles, nanomaterials.
Abstract: The application of nanotechnology to stem cell research and development has made great strides during the last years. Nanotechnology offers a new opportunity for the research and development of stem cells. The mammary gland is a dynamic organ that undergoes extensive morphogenesis during the different stages of embryonic development, puberty, pregnancy, lactation and involution. There are multipotent stem cells that reside in mammary tissue (MaSCs) with the ability to self-renew and even differentiate into all types of mammary cells. To identify, characterize, and differentiate MaSCs, a variety of methods have been used to understand the signal transduction pathways that promote their self-renewal and their cellular fate. In the last decade, stem cell therapy has become a promising and modern topic of scientific research, which has raised great expectations. However, by itself, it presents some problems that have been overcome with the use of nanoparticles (NPs). A triple function has been accomplished: transport of drugs or biomolecules that help in the differentiation and proliferation of stem cells, cell targeting and contrast agents for real-time monitoring and obtaining bioimages for diagnostic and detection systems. The main objective of applying stem cells in conjunction with NPs is to control cellular activity, mainly the regenerative capacity of mammary tissue against diseases such as mastitis or to optimize milk production. In this review, we provide a current overview of the application of nanomaterials on stem cells, specifically bovine stem cells in both the mammary gland and milk, as they are a potential source of cell progenitors with potential characteristics and could be used in potential therapies based on these cells.
Export Options
About this article
Cite this article as:
Marco Viteri , Fernanda Toscano , Alex Gavilanes, Marbel Arias Torres and Rachid Seqqat *, Stem Cells and Nanoparticles in Therapy, Nanoscience & Nanotechnology-Asia 2021; 11 (5) : e010121189823 . https://dx.doi.org/10.2174/2210681210999210101155808
DOI https://dx.doi.org/10.2174/2210681210999210101155808 |
Print ISSN 2210-6812 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6820 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Base Excision Repair: Contribution to Tumorigenesis and Target in Anticancer Treatment Paradigms
Current Medicinal Chemistry Signal Transduction Therapy Targeting Apoptosis Pathways in Cancers
Current Signal Transduction Therapy The Function of LncRNA FTX in Several Common Cancers
Current Pharmaceutical Design Vitamin D Receptor Agonists: Opportunities and Challenges in Drug Discovery
Current Topics in Medicinal Chemistry Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Ceramic Nanoparticles: Fabrication Methods and Applications in Drug Delivery
Current Pharmaceutical Design The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration
Current Drug Targets In Vitro Models of Human T Cell Development: Dishing Out Progenitor T Cells
Current Immunology Reviews (Discontinued) The Emerging Role of Exosomal Non-coding RNAs in Musculoskeletal Diseases
Current Pharmaceutical Design The Pathophysiological Role of PEDF in Bone Diseases
Current Molecular Medicine Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for Cancer
Current Drug Targets Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer
Current Pharmaceutical Design Osteopontin; as a Target Molecule for the Treatment of Inflammatory Diseases
Current Drug Targets Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies
Anti-Cancer Agents in Medicinal Chemistry Insulin-like Growth Factor: Current Concepts and New Developments in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Tumor Protein p63/microRNA Network in Epithelial Cancer Cells
Current Genomics Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1<sup>®</sup> can Overcome Drug Resistance in Osteosarcoma
Current Cancer Drug Targets Inhibition of Apoptosis in Pediatric Cancer by Survivin
Current Pediatric Reviews Topotecan and Irinotecan in the Treatment of Pediatric Solid Tumors
Current Pediatric Reviews Synthetic Src-Kinase Domain Inhibitors and Their Structural Requirements
Anti-Cancer Agents in Medicinal Chemistry